AAPL294.30-2.71 (-0.91%) ▼|ABBV233.23-1.53 (-0.65%) ▼|ABT91.02+0.49 (+0.54%) ▲|ACN128.32+1.31 (+1.03%) ▲|ADBE200.14+2.71 (+1.37%) ▲|AMAT587.97+2.09 (+0.36%) ▲|AMD518.31-1.54 (-0.30%) ▼|AMGN351.38+4.37 (+1.26%) ▲|AMT174.81-4.57 (-2.55%) ▼|AMZN241.29+7.18 (+3.07%) ▲|AVGO385.58+5.43 (+1.43%) ▲|AXP342.40+4.62 (+1.37%) ▲|BA221.13+4.42 (+2.04%) ▲|BAC57.72-0.20 (-0.34%) ▼|BKNG183.47+14.53 (+8.60%) ▲|BLK984.16-31.17 (-3.07%) ▼|BMY55.29-0.25 (-0.44%) ▼|BNY145.71-1.58 (-1.07%) ▼|BRK-B496.34+3.53 (+0.72%) ▲|C144.26-0.71 (-0.49%) ▼|CAT1,000.22+15.98 (+1.62%) ▲|CL92.42+0.99 (+1.08%) ▲|CMCSA22.72-0.08 (-0.35%) ▼|COF202.07+4.26 (+2.15%) ▲|COP106.34-3.63 (-3.30%) ▼|COST962.15+4.47 (+0.47%) ▲|CRM155.16+1.74 (+1.13%) ▲|CSCO122.07+0.92 (+0.76%) ▲|CVS100.14-1.43 (-1.41%) ▼|CVX170.95-5.03 (-2.86%) ▼|DE607.33+15.39 (+2.60%) ▲|DHR188.00+9.03 (+5.05%) ▲|DIS103.90+0.37 (+0.36%) ▲|DUK125.22+0.17 (+0.14%) ▲|EMR143.84+0.70 (+0.49%) ▲|FDX312.67-4.57 (-1.44%) ▼|GD345.92-4.43 (-1.26%) ▼|GE367.75+11.28 (+3.16%) ▲|GEV1,061.97+26.99 (+2.61%) ▲|GILD125.53+0.48 (+0.38%) ▲|GM79.72+0.77 (+0.98%) ▲|GOOG351.73+5.65 (+1.63%) ▲|GOOGL352.40+6.31 (+1.82%) ▲|GS1,081.71-12.73 (-1.16%) ▼|HD338.99+14.54 (+4.48%) ▲|HON228.52+6.15 (+2.76%) ▲|IBM263.03-1.91 (-0.72%) ▼|INTC135.30+3.02 (+2.28%) ▲|INTU266.49+8.44 (+3.27%) ▲|ISRG404.56+1.38 (+0.34%) ▲|JNJ239.90+0.82 (+0.34%) ▲|JPM332.88-1.27 (-0.38%) ▼|KO81.26+0.95 (+1.18%) ▲|LIN520.77+8.51 (+1.66%) ▲|LLY1,106.33-0.76 (-0.07%) ▼|LMT496.16-7.51 (-1.49%) ▼|LOW221.27+7.73 (+3.62%) ▲|LRCX370.22-1.11 (-0.30%) ▼|MA496.11+8.04 (+1.65%) ▲|MCD273.96+2.30 (+0.85%) ▲|MDLZ62.20+1.14 (+1.87%) ▲|MDT80.73+0.10 (+0.12%) ▲|META565.67+3.47 (+0.62%) ▲|MMM167.96+6.12 (+3.78%) ▲|MO71.51-0.10 (-0.14%) ▼|MRK119.57-0.03 (-0.03%) ▼|MS222.58-3.45 (-1.53%) ▼|MSFT373.94+6.60 (+1.80%) ▲|MU1,044.62-7.15 (-0.68%) ▼|NEE86.61+0.18 (+0.21%) ▲|NFLX72.42-0.40 (-0.55%) ▼|NKE41.88-0.51 (-1.19%) ▼|NOW95.66-0.28 (-0.29%) ▼|NVDA201.15+1.15 (+0.58%) ▲|ORCL160.23-4.93 (-2.99%) ▼|PEP143.07+1.02 (+0.72%) ▲|PFE24.34-0.38 (-1.52%) ▼|PG152.76+1.90 (+1.26%) ▲|PLTR115.34-1.37 (-1.17%) ▼|PM177.59-1.10 (-0.62%) ▼|QCOM199.00-5.13 (-2.51%) ▼|RTX185.80-0.59 (-0.32%) ▼|SBUX103.14+2.09 (+2.07%) ▲|SCHW91.77-1.41 (-1.51%) ▼|SO94.79-0.14 (-0.15%) ▼|SPG218.26+1.52 (+0.70%) ▲|T22.52-0.30 (-1.29%) ▼|TMO487.55+18.20 (+3.88%) ▲|TMUS183.52-1.05 (-0.57%) ▼|TSLA382.92+1.31 (+0.34%) ▲|TXN305.33+0.97 (+0.32%) ▲|UBER74.72+5.05 (+7.25%) ▲|UNH403.79-5.47 (-1.34%) ▼|UNP262.44+3.83 (+1.48%) ▲|UPS105.65-0.18 (-0.17%) ▼|USB60.10+0.05 (+0.08%) ▲|V332.54+4.06 (+1.23%) ▲|VZ45.84-0.90 (-1.92%) ▼|WFC83.96-0.17 (-0.20%) ▼|WMT119.78+0.36 (+0.30%) ▲|XOM135.81-3.92 (-2.81%) ▼|AAPL294.30-2.71 (-0.91%) ▼|ABBV233.23-1.53 (-0.65%) ▼|ABT91.02+0.49 (+0.54%) ▲|ACN128.32+1.31 (+1.03%) ▲|ADBE200.14+2.71 (+1.37%) ▲|AMAT587.97+2.09 (+0.36%) ▲|AMD518.31-1.54 (-0.30%) ▼|AMGN351.38+4.37 (+1.26%) ▲|AMT174.81-4.57 (-2.55%) ▼|AMZN241.29+7.18 (+3.07%) ▲|AVGO385.58+5.43 (+1.43%) ▲|AXP342.40+4.62 (+1.37%) ▲|BA221.13+4.42 (+2.04%) ▲|BAC57.72-0.20 (-0.34%) ▼|BKNG183.47+14.53 (+8.60%) ▲|BLK984.16-31.17 (-3.07%) ▼|BMY55.29-0.25 (-0.44%) ▼|BNY145.71-1.58 (-1.07%) ▼|BRK-B496.34+3.53 (+0.72%) ▲|C144.26-0.71 (-0.49%) ▼|CAT1,000.22+15.98 (+1.62%) ▲|CL92.42+0.99 (+1.08%) ▲|CMCSA22.72-0.08 (-0.35%) ▼|COF202.07+4.26 (+2.15%) ▲|COP106.34-3.63 (-3.30%) ▼|COST962.15+4.47 (+0.47%) ▲|CRM155.16+1.74 (+1.13%) ▲|CSCO122.07+0.92 (+0.76%) ▲|CVS100.14-1.43 (-1.41%) ▼|CVX170.95-5.03 (-2.86%) ▼|DE607.33+15.39 (+2.60%) ▲|DHR188.00+9.03 (+5.05%) ▲|DIS103.90+0.37 (+0.36%) ▲|DUK125.22+0.17 (+0.14%) ▲|EMR143.84+0.70 (+0.49%) ▲|FDX312.67-4.57 (-1.44%) ▼|GD345.92-4.43 (-1.26%) ▼|GE367.75+11.28 (+3.16%) ▲|GEV1,061.97+26.99 (+2.61%) ▲|GILD125.53+0.48 (+0.38%) ▲|GM79.72+0.77 (+0.98%) ▲|GOOG351.73+5.65 (+1.63%) ▲|GOOGL352.40+6.31 (+1.82%) ▲|GS1,081.71-12.73 (-1.16%) ▼|HD338.99+14.54 (+4.48%) ▲|HON228.52+6.15 (+2.76%) ▲|IBM263.03-1.91 (-0.72%) ▼|INTC135.30+3.02 (+2.28%) ▲|INTU266.49+8.44 (+3.27%) ▲|ISRG404.56+1.38 (+0.34%) ▲|JNJ239.90+0.82 (+0.34%) ▲|JPM332.88-1.27 (-0.38%) ▼|KO81.26+0.95 (+1.18%) ▲|LIN520.77+8.51 (+1.66%) ▲|LLY1,106.33-0.76 (-0.07%) ▼|LMT496.16-7.51 (-1.49%) ▼|LOW221.27+7.73 (+3.62%) ▲|LRCX370.22-1.11 (-0.30%) ▼|MA496.11+8.04 (+1.65%) ▲|MCD273.96+2.30 (+0.85%) ▲|MDLZ62.20+1.14 (+1.87%) ▲|MDT80.73+0.10 (+0.12%) ▲|META565.67+3.47 (+0.62%) ▲|MMM167.96+6.12 (+3.78%) ▲|MO71.51-0.10 (-0.14%) ▼|MRK119.57-0.03 (-0.03%) ▼|MS222.58-3.45 (-1.53%) ▼|MSFT373.94+6.60 (+1.80%) ▲|MU1,044.62-7.15 (-0.68%) ▼|NEE86.61+0.18 (+0.21%) ▲|NFLX72.42-0.40 (-0.55%) ▼|NKE41.88-0.51 (-1.19%) ▼|NOW95.66-0.28 (-0.29%) ▼|NVDA201.15+1.15 (+0.58%) ▲|ORCL160.23-4.93 (-2.99%) ▼|PEP143.07+1.02 (+0.72%) ▲|PFE24.34-0.38 (-1.52%) ▼|PG152.76+1.90 (+1.26%) ▲|PLTR115.34-1.37 (-1.17%) ▼|PM177.59-1.10 (-0.62%) ▼|QCOM199.00-5.13 (-2.51%) ▼|RTX185.80-0.59 (-0.32%) ▼|SBUX103.14+2.09 (+2.07%) ▲|SCHW91.77-1.41 (-1.51%) ▼|SO94.79-0.14 (-0.15%) ▼|SPG218.26+1.52 (+0.70%) ▲|T22.52-0.30 (-1.29%) ▼|TMO487.55+18.20 (+3.88%) ▲|TMUS183.52-1.05 (-0.57%) ▼|TSLA382.92+1.31 (+0.34%) ▲|TXN305.33+0.97 (+0.32%) ▲|UBER74.72+5.05 (+7.25%) ▲|UNH403.79-5.47 (-1.34%) ▼|UNP262.44+3.83 (+1.48%) ▲|UPS105.65-0.18 (-0.17%) ▼|USB60.10+0.05 (+0.08%) ▲|V332.54+4.06 (+1.23%) ▲|VZ45.84-0.90 (-1.92%) ▼|WFC83.96-0.17 (-0.20%) ▼|WMT119.78+0.36 (+0.30%) ▲|XOM135.81-3.92 (-2.81%) ▼|
24.7 C
New York
Wednesday, June 24, 2026

Tag: medicine

newssourceFORcompanyinformationcontent1marketreleases

Longeveron® Announces U.S. FDA Approval of IND Application for a Phase 2 Pivotal Registration Study Evaluating Laromestrocel as a Treatment of Pediatric Dilated Cardiomyopathy...

FDA approves Longeveron's Investigational New Drug (IND) application for stem cell therapy as a potential treatment for pediatric dilated cardiomyopathy.

Zuellig Pharma Launches “Obesity is a Disease” Seminar as Part of “Reduce Size, Reduce Disease” Campaign

The campaign aims to enhance the understanding of obesity as a chronic disease and solutions to help manage the disease among Thais and healthcare...

Novartis receives approval for first malaria medicine for newborn babies and young infants

Basel, July 8, 2025 – Novartis today announced Coartem® (artemether-lumefantrine) Baby has been approved by Swissmedic as the first malaria medicine for newborns and young infants. The new treatment, also known as Riamet® Baby in some countries, was developed in collaboration with Medicines for Malaria Venture (MMV) to treat the potentially deadly mosquito-borne disease.

Johnson & Johnson Launches VARIPULSE™ Platform across Asia-Pacific, Advancing Atrial Fibrillation Treatment

The VARIPULSE™ Platform is the first Pulsed Field Ablation (PFA) system fully integrated with the CARTO™ 3 electroanatomical mapping system, designed to drive efficiency,...

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages 3D Systems Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – DDD

NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of 3D Systems Corporation (NYSE: DDD) between August 13, 2024 and May 12, 2025, both dates inclusive (the “Class Period”), of the important August 12, 2025 lead plaintiff deadline.

Leading Medical Professional Societies, Patient Sue HHS, Robert F. Kennedy, Jr., for Unilateral Vaccine Changes

AAP, ACP, APHA, IDSA, MPHA, and SMFM Join Together to Stop Assault on Public Health BOSTON, July 7, 2025 /PRNewswire/ -- Today, the American Academy...

INOVIO to Present at Upcoming Scientific Conference

PLYMOUTH MEETING, Pa., July 7, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and...

Better by MTA Highlights Platinum Members Elevating Global Healthcare Standards

PALM BEACH GARDENS, Fla., July 7, 2025 /PRNewswire/ -- Better by MTA, the leading medical tourism platform, is proud to spotlight its distinguished Platinum Members—organizations...

Lifeforce and Toku Combine AI Retinal Scans with the World’s Largest Longevity-Medicine Platform to Take Steps to Slow Aging and Reduce Cardiovascular Risk

SANTA MONICA, Calif., July 7, 2025 /PRNewswire/ -- Lifeforce, the world's largest longevity medicine platform, and Toku, a health technology company using AI to...

Simplex Quantum Welcomes Dr. Marco Perez as an Advisor to Advance AI-Driven Heart Failure Detection

TOKYO, July 7, 2025 /PRNewswire/ -- Simplex Quantum, an AI-driven healthcare technology company, is proud to announce that Dr. Marco Perez, Associate Professor of...

Ipsen – Half year statement – 2025 06 30

Half-year statement of IPSEN liquidity agreement with NATIXIS ODDO BHF

mRNA Sequencing Market Size to Hit USD 4.02 billion by 2031, Growing at 13.6% CAGR, Benefits from Surging Prevalence of Cancer | The Insight...

NEW YORK, July 7, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global mRNA sequencing market is observing...

Smith+Nephew expands market-leading fixation strength of Q-FIX™ All-Suture Anchor portfolio with new knotless option

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the release of its Q-FIX KNOTLESS All-Suture Anchor for soft tissue-to-bone fixation indications across multiple joint spaces including Shoulder, Hip, and Foot & Ankle. 

MY DR NOW Opens Tucson Clinic, Ushering in a New Era of Convenient Care for Southern Arizona

TUCSON, Ariz., July 7, 2025 /PRNewswire/ -- Southern Arizona is getting another dose of hassle-free healthcare as MY DR NOW opens its next clinic...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsMedicine

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers